S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
USOTC
Roquefort Therapeutics PLC (PK) (ROQAF)
Roquefort Therapeutics PLC (PK) (ROQAF) Financials

Roquefort Therapeutics PLC (PK) (ROQAF)

0.05

0.00

(0.00%)

Closed November 27 3:00PM

Delayed by 15 minutes

Roquefort Therapeutics PLC (PK) Financial Summary

The current ROQAF market cap is 6.46M. The company's latest EPS is GBP -0.0135 and P/E is -3.07.

Income Statement

Year End December 30 2023	2021	2022	2023
	GBP (£)	GBP (£)	GBP (£)
Total Revenue	1,000	0	200k
Operating Income	-916k	-1.63M	-1.93M
Net Income	-916k	-1.62M	-1.75M

Balance Sheet

Year End December 30 2023	2021	2022	2023
	GBP (£)	GBP (£)	GBP (£)
Total Assets	4.56M	7.77M	6.09M
Total Liabilities	477k	561k	589k
Total Equity	4.08M	7.21M	5.5M

Cash Flow

Year End December 30 2023	2021	2022	2023
	GBP (£)	GBP (£)	GBP (£)
Operating	-516k	-1.58M	-1.73M
Investing	-606k	-103k	-53k
Financing	2.02M	3.1M	N/A

Stats and Ratios

Market Cap	6.46M
Price to Earnings Ratio	-3.07
Price to Sales Ratio	27.67
Price to Cash Ratio	9.88
Price to Book Ratio	0.97
Dividend Yield	-

Share Statistics

Shares Outstanding	129.15M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-51.64%
52 Week High	0.1034
52 Week Low	0.049
Spread (Intraday)	368.08 (100%)

Company Info

Company Name	Roquefort Therapeutics PLC (PK)
Address	85 great portland street london W1W 7LT
Website	https://www.roquefortplc.com
Industry	cmp integrated sys design (7373)

Roquefort Therapeutics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions